
Aspergillus niger (A.niger) is a popular industrial production strain due to its ability to achieve high enzyme production yields. However, only the right combination of target protein and microorganism leads to high production yields and thus to economical production processes. But what is the right combination?
Our Plug & Produce System enables us to quickly determine whether your protein can be efficiently expressed in our proprietary A. niger production strain before embarking on full strain development. This early feasibility assessment helps you to:
The expression platform on which the system is based is our industrial A. niger production strain, whose genome allows directed multicopy integration of several "gene expression cassettes" at the same time.
Our platform is built on a proprietary industrial BSL-1 Aspergillus niger strain designed for high-level protein production.
Key capabilities include:
The platform provides a reliable starting point for developing scalable manufacturing processes.
Once we have confirmed that your target protein is suitable for production in Aspergillus, we move directly into strain and process optimization. Using our proprietary CRISPR-BMC genome engineering technology, we tailor the production strain to maximize expression, productivity and process robustness.
Unlike conventional development approaches, we optimize the production strain and fermentation process simultaneously. This integrated workflow accelerates development and helps unlock the full production potential of your molecule.
Our Plug & Produce System is ideally suited for companies developing:
We offer this technology through our R&D division at the Zwingenberg site, and customers in the fields of enzyme production and precision fermentation in particular can benefit from this platform.
With our A.niger production strains and matching fermentation processes, we are able to achieve high production yields for enzymes and proteins. In this way, we help our customers to meet the high demand in various application areas with highly economical production processes.
Benefits in a nutshell:
How we found an alternative genome-editing platform for engineering industrial strains
This case study shows how we took a holistic approach and combined technologies to provide a more efficient enzyme tailored to the needs of a specific industrial application.
Side streams can be transformed into innovative products: An example from the wine industry
Accelerate enzyme discovery with the MetXtra™ technology platform and pave the way for your breakthrough in industrial biocatalysis
It can be difficult to produce CRISPR nucleases for use as RNPs. This case study demonstrates how we found a solution.
Finding the right enzyme quickly with our directed enzyme panels.
When every stage of enzyme development is connected, innovation moves faster, risks are reduced, and better outcomes become possible.
An enzyme engineered version of BRAIN Biotech´s CRISPR-BMC with superior properties in yeasts accelerates development of high-performance strains.
Discover how targeted enzymatic conversion of soy lecithin into high-performance lysolecithin enhances functionality, stability, and commercial value.
Unlocking the full potential of sunflower lecithin through targeted phospholipase A2 conversion to high-performance lyso-lecithin